474 related articles for article (PubMed ID: 21289053)
41. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway.
Hao L; Du M; Lopez-Campistrous A; Fernandez-Patron C
Circ Res; 2004 Jan; 94(1):68-76. PubMed ID: 14656925
[TBL] [Abstract][Full Text] [Related]
42. Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors.
Zhang D; Zhang J; Jiang X; Li X; Wang Y; Ma J; Jiang H
J Gastroenterol Hepatol; 2014 Mar; 29(3):623-32. PubMed ID: 24303948
[TBL] [Abstract][Full Text] [Related]
43. Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling.
Maurya SK; Rai A; Rai NK; Deshpande S; Jain R; Mudiam MK; Prabhakar YS; Bandyopadhyay S
Toxicol Sci; 2012 Feb; 125(2):473-87. PubMed ID: 22048644
[TBL] [Abstract][Full Text] [Related]
44. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
45. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
Roztocil E; Nicholl SM; Davies MG
Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
[TBL] [Abstract][Full Text] [Related]
46. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
47. Elevated transcriptional co-activator p102 mediates angiotensin II type 1 receptor up-regulation and extracellular matrix overproduction in the high glucose-treated rat glomerular mesangial cells and isolated glomeruli.
Wang Z; Ni J; Shao D; Liu J; Shen Y; Zhou L; Huang Y; Yu C; Wang J; Xue H; Lu L
Eur J Pharmacol; 2013 Feb; 702(1-3):208-17. PubMed ID: 23376562
[TBL] [Abstract][Full Text] [Related]
48. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Gao B; Krepinsky JC
Diabetologia; 2007 Sep; 50(9):2008-2018. PubMed ID: 17622510
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.
Taniguchi K; Xia L; Goldberg HJ; Lee KW; Shah A; Stavar L; Masson EA; Momen A; Shikatani EA; John R; Husain M; Fantus IG
Diabetes; 2013 Nov; 62(11):3874-86. PubMed ID: 23942551
[TBL] [Abstract][Full Text] [Related]
50. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
51. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
[TBL] [Abstract][Full Text] [Related]
52. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
[TBL] [Abstract][Full Text] [Related]
53. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells.
Zhuang S; Kinsey GR; Rasbach K; Schnellmann RG
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F459-68. PubMed ID: 18171996
[TBL] [Abstract][Full Text] [Related]
54. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
55. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
56. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
[TBL] [Abstract][Full Text] [Related]
57. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway.
Ancha HR; Kurella RR; Stewart CA; Damera G; Ceresa BP; Harty RF
Int J Biochem Cell Biol; 2007; 39(11):2143-52. PubMed ID: 17656145
[TBL] [Abstract][Full Text] [Related]
58. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
[TBL] [Abstract][Full Text] [Related]
59. Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.
Sloss CM; Wang F; Palladino MA; Cusack JC
Oncogene; 2010 May; 29(21):3146-52. PubMed ID: 20208558
[TBL] [Abstract][Full Text] [Related]
60. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.
Jackson LF; Qiu TH; Sunnarborg SW; Chang A; Zhang C; Patterson C; Lee DC
EMBO J; 2003 Jun; 22(11):2704-16. PubMed ID: 12773386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
